论文部分内容阅读
目的探讨术前经导管动脉化学栓塞(TACE)联合手术治疗肝癌的临床疗效。方法以该院100例确诊肝癌患者作为目标人群,随机分为二组,观察组与对照组,每组50例。比较二组患者治疗疗效、KPS评分、不良反应发生率情况。结果观察组患者显效率明显高于对照组,差异有统计学意义(P<0.01);观察组总有效率明显高于对照组,差异有统计学意义(P<0.05);观察组治疗后KPS评分明显升高,差异有统计学意义(P<0.05)二组患者治疗后KPS评分差异有统计学意义(P<0.05)。二组患者副作用发生率差异无统计学意义(P>0.05)。结论术前TACE联合手术治疗肝癌的临床疗效显著,具有借鉴性。
Objective To investigate the clinical effect of preoperative transcatheter arterial chemoembolization (TACE) combined with surgical treatment of liver cancer. Methods A total of 100 patients with confirmed HCC were enrolled in this study. Patients were randomly divided into two groups: observation group and control group, with 50 cases in each group. The curative effect, KPS score and incidence of adverse reactions in the two groups were compared. Results The effective rate in the observation group was significantly higher than that in the control group (P <0.01), and the total effective rate in the observation group was significantly higher than that in the control group (P <0.05). The KPS The score was significantly higher (P <0.05). There was significant difference in KPS score between the two groups after treatment (P <0.05). There was no significant difference in the incidence of side effects between the two groups (P> 0.05). Conclusion Preoperative TACE combined with surgical treatment of liver cancer significant clinical effect, with reference.